Graf Akcie EMMA (Emmaus Life Sciences Incorporation). Diskuze k akciím EMMA. Aktuální informace EMMA.

Základní informace o společnosti Emmaus Life Sciences Incorporation (Akcie EMMA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 73.97M
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -615.00
Růst v tržbách Q/Q -4.57 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 4.22
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 3.12
P/FCF N/A
Price/Book -13.65
Účetní hodnota na akcii -0.12
Hotovost na akcii N/A
FCF vůči ceně N/A %
Počet zaměstnanců 57
Tržba na zaměstnance N/A
Profit margin 4.75 %
Operating margin -3.22 %
Gross margin 90.30 %
EBIT margin N/A %
EBITDA margin -736.85 %
EPS - Zisk na akcii 0.00
EPS - Kvartální růst -56.52 %
EPS - Očekávaný růst příští rok N/A %
Return on assets -0.80 %
Return on equity N/A %
ROIC -0.08 %
ROCE -5.78 %
Dluhy/Equity -11.94
Čistý dluh/EBITDA N/A
Current ratio 0.64
Quick Ratio 0.27
Volatilita 9.79
Beta 0.00
RSI 51.10
Cílová cena analytiků 24
Známka akcie (dle analytiků) N/A
Insider ownership 40.64 %
Institutional ownership 0.00 %
Počet akcií 49.312M
Procento shortovaných akcií 0.09 %
Short ratio 0.48 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie EMMA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$22.752$16.459$1.316$0.129$0.085$0.1
Cost Of Goods Sold$1.094$0.993$0.827$0.054$0.006$0.005
Gross Profit$21.658$15.466$0.488$0.075$0.08$0.095
Research And Development Expenses$2.183$1.723$1.378$1.361$0.794$0.784
SG&A Expenses$23.987$22.197$9.356$5.818$3.052$1.961
Other Operating Income Or Expenses------
Operating Expenses$27.264$24.913$11.56$7.232$3.852$2.75
Operating Income$-4.512$-8.454$-10.245$-7.104$-3.767$-2.65
Total Non-Operating Income/Expense$-50.166$-64.094$-0.086$-0.007$-2.172$-0.725
Pre-Tax Income$-54.678$-72.548$-10.331$-7.11$-5.939$-3.374
Income Taxes$0.164$0.039$0.002$0.003$0.002$0.005
Income After Taxes$-54.842$-72.587$-10.333$-7.113$-5.941$-3.379
Other Income------
Income From Continuous Operations$-54.842$-72.587$-10.333$-7.113$-5.941$-3.379
Income From Discontinued Operations------
Net Income$-54.842$-72.587$-9.599$-7.113$-5.941$-3.379
EBITDA$19.342$9.841$-10.045$-7.055$-3.76$-2.642
EBIT$-4.512$-8.454$-10.245$-7.104$-3.767$-2.65
Basic Shares Outstanding42371000
Shares Outstanding42371000
Basic EPS$-1.30$-1.97$-11.16$-15.12$-55.55$-39.83
EPS - Earnings Per Share$-1.30$-1.97$-11.16$-15.12$-55.55$-39.83
# 2020 2019 2018 2017 2016 2015
Current Ratio1.25571.33053.01243.68490.26090.3037
Long-term Debt / Capital--2.2070.15220.0007-0.0351-1.3357
Debt/Equity Ratio-1.3166-1.74870.17990.008-0.0879-0.5724
Gross Margin95.191693.966837.103858.365893.53795.1049
Operating Margin-19.8312-51.364-778.7837-5528.094-4426.322-2647.153
EBIT Margin-19.8312-51.364-778.7837-5528.094-4426.322-2647.153
EBITDA Margin85.012359.791-763.5652-5490.195-4417.861-2639.56
Pre-Tax Profit Margin-240.3217-440.7801-785.3439-5533.229-6978.731-3371.029
Net Profit Margin-241.0425-441.0171-729.6617-5535.253-6981.081-3376.024
Asset Turnover0.38270.21860.25530.02110.16620.1765
Inventory Turnover Ratio0.13720.2111----
Receiveable Turnover10.58239.205320.78219.769216.68638.4831
Days Sales In Receivables34.491539.651317.563318.46321.874343.027
ROE - Return On Equity496.173334.3791-314.5159-156.4146558.093669.8729
Return On Tangible Equity496.1729334.379-579.4695-158.5131515.882369.6841
ROA - Return On Assets-92.2396-96.4253-200.5726-116.6779-1160.105-595.909
ROI - Return On Investment496.1731072.344-266.5712-156.2978577.6838163.2008
Book Value Per Share-0.228-0.58132.66176.3454-3.2899-56.6664
Operating Cash Flow Per Share0.045910.2743-0.222417.6252-2.415814.0975
Free Cash Flow Per Share0.046910.3354-0.013717.3902-2.470814.1152